Development Level

Tbio 37 | 10,625
Tchem 27 | 1,890
Tclin 5 | 602
Tdark 3 | 7,003

Collection

Eligible Kinase Proteins 1 | 134

IMPC Term

increased or absent threshold ... 3 | 128
decreased heart weight 2 | 44
increased circulating bilirubi... 2 | 16
preweaning lethality, complete... 2 | 633
preweaning lethality, incomple... 2 | 260
abnormal behavior 1 | 226
abnormal behavioral response t... 1 | 52
abnormal bone mineralization 1 | 55
abnormal embryo size 1 | 112
abnormal gait 1 | 51
abnormal lens morphology 1 | 73
abnormal tibia morphology 1 | 14
abnormal vertebrae morphology 1 | 14
absent optic nerve 1 | 1
cataract 1 | 26
corneal opacity 1 | 25
decreased body length 1 | 108
decreased body weight 1 | 174
decreased bone mineral density 1 | 126
decreased circulating HDL chol... 1 | 77
decreased circulating chloride... 1 | 32
decreased circulating choleste... 1 | 85
decreased circulating creatini... 1 | 31
decreased circulating glucose ... 1 | 121
decreased circulating insulin ... 1 | 75
decreased circulating triglyce... 1 | 83
decreased heart rate 1 | 10
decreased lean body mass 1 | 195
decreased mean corpuscular vol... 1 | 50
decreased mean platelet volume 1 | 12
decreased startle reflex 1 | 48
decreased thermal nociceptive ... 1 | 4
decreased threshold for audito... 1 | 32
embryonic lethality prior to o... 1 | 148
embryonic lethality prior to t... 1 | 187
hyperactivity 1 | 108
improved glucose tolerance 1 | 56
increased circulating HDL chol... 1 | 63
increased circulating choleste... 1 | 53
increased circulating phosphat... 1 | 24
increased circulating potassiu... 1 | 31
increased circulating triglyce... 1 | 24
increased grip strength 1 | 83
increased heart weight 1 | 37
increased hematocrit 1 | 36
increased mean corpuscular hem... 1 | 93
increased vertical activity 1 | 18
shortened QRS complex duration 1 | 1
thrombocytopenia 1 | 46

Disease

psoriasis 44 | 6,685
ovarian cancer 36 | 8,484
Obesity 34 | 616
osteosarcoma 28 | 7,933
medulloblastoma, large-cell 26 | 6,234
diabetes mellitus 25 | 1,663
invasive ductal carcinoma 24 | 2,950
lung cancer 23 | 4,466
pancreatic ductal adenocarcinoma liver metastasis 23 | 1,795
ductal carcinoma in situ 22 | 1,745
glioblastoma 21 | 5,572
malignant mesothelioma 20 | 3,162
intraductal papillary-mucinous neoplasm (IPMN) 18 | 3,289
Cancer 17 | 2,346
Metabolic syndrome X 17 | 155
intraductal papillary-mucinous adenoma (IPMA) 17 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 17 | 2,988
lung carcinoma 17 | 2,844
ulcerative colitis 17 | 2,087
Atherosclerosis 16 | 275
Atopic dermatitis 16 | 944
Lipid metabolism disorder 16 | 102
breast carcinoma 16 | 1,614
interstitial cystitis 16 | 2,299
Breast cancer 15 | 3,094
Coronary artery disease 15 | 240
pancreatic cancer 15 | 2,300
astrocytoma 14 | 1,493
colon cancer 14 | 1,475
pilocytic astrocytoma 14 | 3,086
active Crohn's disease 13 | 918
non-small cell lung cancer 13 | 2,798
pituitary cancer 13 | 1,972
Fatty liver disease 12 | 84
atypical teratoid / rhabdoid tumor 12 | 4,369
oligodendroglioma 12 | 2,849
pediatric high grade glioma 12 | 2,712
astrocytic glioma 11 | 2,241
fibroadenoma 11 | 557
lung adenocarcinoma 11 | 2,713
adrenocortical carcinoma 10 | 1,427
primitive neuroectodermal tumor 10 | 3,031
Rheumatoid Arthritis 9 | 1,160
ependymoma 9 | 2,514
group 3 medulloblastoma 9 | 2,254
group 4 medulloblastoma 9 | 1,875
nephrosclerosis 9 | 329
posterior fossa group B ependymoma 9 | 1,530
subependymal giant cell astrocytoma 9 | 2,287
Hyperglycemia 8 | 120
Liver carcinoma 8 | 217
acute quadriplegic myopathy 8 | 1,157
cystic fibrosis 8 | 1,665
mucosa-associated lymphoid tissue lymphoma 8 | 480
Diabetes Mellitus, Experimental 7 | 106
Heart disease 7 | 279
Hypertension 7 | 287
Hypertensive disease 7 | 193
Myocardial Ischemia 7 | 169
active ulcerative colitis 7 | 477
adult high grade glioma 7 | 2,148
atypical teratoid/rhabdoid tumor 7 | 1,095
cutaneous lupus erythematosus 7 | 1,056
nasopharyngeal carcinoma 7 | 1,056
tuberculosis 7 | 1,557
Animal Mammary Neoplasms 6 | 136
Drug-Induced Liver Injury 6 | 118
Kidney disease 6 | 396
Liver Cirrhosis, Experimental 6 | 108
Mammary Neoplasms, Experimental 6 | 150
Pick disease 6 | 1,893
Zellweger Syndrome 6 | 38
aldosterone-producing adenoma 6 | 664
posterior fossa group A ependymoma 6 | 1,511
Adrenoleukodystrophy 5 | 31
Cerebrovascular disease 5 | 231
Down syndrome 5 | 548
Duchenne muscular dystrophy 5 | 602
Dyslipidemias 5 | 17
Hypertriglyceridemia 5 | 18
Hypoglycemia 5 | 81
Insulin Resistance 5 | 48
Liver disease 5 | 219
Mammary Neoplasms 5 | 410
Peripheral Neuropathy 5 | 303
Polycystic Ovary Syndrome 5 | 332
Weight Gain 5 | 87
autosomal dominant Emery-Dreifuss muscular dystrophy 5 | 499
dermatomyositis 5 | 933
hereditary spastic paraplegia 5 | 313
non primary Sjogren syndrome sicca 5 | 840
Alzheimer's disease 4 | 644
Arthritis 4 | 248
Multiple myeloma 4 | 1,327
Prostatic Neoplasms 4 | 471
chronic lymphosyte leukemia 4 | 232
inflammatory breast cancer 4 | 404
juvenile dermatomyositis 4 | 1,189
pancreatic carcinoma 4 | 567
primary pancreatic ductal adenocarcinoma 4 | 1,271

Tissue

Blood and immune system 72 | 17,995
Cardiovascular System 72 | 17,958
Digestive Tract 72 | 18,473
Endocrine System 72 | 18,512
Female tissues 72 | 18,647
Liver and Pancreas 72 | 18,136
Male tissues 72 | 17,969
Nervous System 72 | 18,561
Skin and soft tissues 72 | 18,115
Urinary Tract 72 | 18,444
Respiratory system 71 | 17,484

Target Family

Non-IDG 28 | 11,971
Enzyme 26 | 4,146
Nuclear Receptor 7 | 48
Kinase 6 | 634
Transporter 5 | 473

KEGG Pathway

PPAR signaling pathway 72 | 72
Metabolic pathways 1,254 | 1,254
Olfactory transduction 412 | 412
Pathways in cancer 402 | 402
HTLV-I infection 339 | 339
PI3K-Akt signaling pathway 338 | 338
Endocytosis 326 | 326
Epstein-Barr virus infection 279 | 279
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 262 | 262
Herpes simplex infection 262 | 262
MAPK signaling pathway 255 | 255
Viral carcinogenesis 253 | 253
Phagosome 231 | 231
Cell adhesion molecules (CAMs) 225 | 225
Ras signaling pathway 225 | 225
Rap1 signaling pathway 213 | 213
Regulation of actin cytoskelet... 213 | 213
Proteoglycans in cancer 202 | 202
cAMP signaling pathway 201 | 201
Focal adhesion 200 | 200
Natural killer cell mediated c... 199 | 199
Huntington's disease 194 | 194
Tuberculosis 187 | 187
Influenza A 184 | 184
Chemokine signaling pathway 182 | 182
Calcium signaling pathway 181 | 181
Axon guidance 176 | 176
Purine metabolism 171 | 171
Alzheimer's disease 169 | 169
Tight junction 169 | 169
NOD-like receptor signaling pa... 168 | 168
Protein processing in endoplas... 165 | 165
Transcriptional misregulation ... 165 | 165
cGMP-PKG signaling pathway 165 | 165
RNA transport 164 | 164
Oxytocin signaling pathway 158 | 158
Jak-STAT signaling pathway 157 | 157
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
mTOR signaling pathway 153 | 153
Non-alcoholic fatty liver dise... 151 | 151
Adrenergic signaling in cardio... 150 | 150
MicroRNAs in cancer 150 | 150
Breast cancer 146 | 146
Alcoholism 145 | 145
Hepatitis B 145 | 145
Phospholipase D signaling path... 145 | 145
Parkinson's disease 142 | 142
Wnt signaling pathway 142 | 142
Signaling pathways regulating ... 141 | 141
Apoptosis 140 | 140
Insulin signaling pathway 138 | 138
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Measles 135 | 135
Ribosome 134 | 134
Oxidative phosphorylation 133 | 133
FoxO signaling pathway 132 | 132
Hepatitis C 132 | 132
Spliceosome 132 | 132
Dopaminergic synapse 131 | 131
Osteoclast differentiation 131 | 131
Autoimmune thyroid disease 130 | 130
Toxoplasmosis 130 | 130
Cell cycle 125 | 125
Platelet activation 124 | 124
AMPK signaling pathway 123 | 123
Lysosome 123 | 123
Type I diabetes mellitus 122 | 122
Vascular smooth muscle contrac... 121 | 121
Graft-versus-host disease 120 | 120
Sphingolipid signaling pathway 120 | 120
Neurotrophin signaling pathway 119 | 119
Oocyte meiosis 119 | 119
Th17 cell differentiation 119 | 119
Thyroid hormone signaling path... 118 | 118
Allograft rejection 116 | 116
Glutamatergic synapse 116 | 116
Leukocyte transendothelial mig... 116 | 116
Carbon metabolism 114 | 114
Serotonergic synapse 114 | 114
Cholinergic synapse 110 | 110
TNF signaling pathway 110 | 110
Insulin resistance 109 | 109
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
Chagas disease (American trypa... 106 | 106
T cell receptor signaling path... 104 | 104
Th1 and Th2 cell differentiati... 104 | 104
Glucagon signaling pathway 103 | 103
HIF-1 signaling pathway 103 | 103
Toll-like receptor signaling p... 103 | 103
Melanogenesis 102 | 102
Pyrimidine metabolism 102 | 102
AGE-RAGE signaling pathway in ... 101 | 101
Endocrine resistance 101 | 101
Estrogen signaling pathway 101 | 101
Retrograde endocannabinoid sig... 101 | 101
Amoebiasis 100 | 100
Rheumatoid arthritis 100 | 100

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interstitial collagenase MMP1 Tchem Enzyme -3.40801 2529.5 682
Apolipoprotein A-I APOA1 Tchem Non-IDG -3.60439 3516.7 901
Apolipoprotein A-II APOA2 Tbio Non-IDG -2.80284 593.9 352
Apolipoprotein C-III APOC3 Tbio Non-IDG -2.90374 836.7 239
Gastrotropin FABP6 Tbio Non-IDG -2.14251 142.9 116
NADP-dependent malic enzyme ME1 Tchem Non-IDG -1.96870 90.3 172
Carnitine O-palmitoyltransferase 1, liver isoform CPT1A Tchem Enzyme -2.30451 203.2 252
Fatty acid-binding protein, intestinal FABP2 Tchem Non-IDG -2.48234 381.1 342
Mitochondrial brown fat uncoupling protein 1 UCP1 Tbio Non-IDG -3.04555 1148.0 252
Fatty acid-binding protein, brain FABP7 Tchem Non-IDG -2.12234 145.0 346